*Five Years Citation in Google scholar (2016 - 2020) is. 1451*   *    IJPR IS INDEXED IN ELSEVIER EMBASE & EBSCO *       

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence
Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
No Data found.
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
In Vitro Dissolution Profile Of Different Brands Of Low Solubility Drugs Available In The Nigerian And Brazilian Pharmaceutical Markets

Author: EZEAGU HENRY IFEANYI, ISSA MICHELE GEORGES, OFOEFULE SABINUS IFEANYI, FERRAZ HUMBERTO GOMES
Abstract: The present work describes the dissolution profiles of different brands of furosemide, glibenclamide, albendazole, ibuprofen, carvedilol and hydrochlorothiazide tablets available in the Nigerian and Brazilian pharmaceutical markets. The dissolution test was performed by following the recommendation of the United States Pharmacopeia (USP), FDA and developed method (carvedilol). A filter selection test was done for the drugs; the results obtained indicated that cannula filter was ideal for all the drugs with the exception of carvedilol which was centrifuged. The ANOVA of the filter selection showed no significant retention of drug with cannula filter (p > 0.05), with the exception of carvedilol (p< 0.05). The data obtained from the dissolution test was subjected to statistical analysis in a Microsoft excel and Minitab 17 (USA). Dissolution efficiency (%DE) was calculated for the formulations to evaluate their in vitro biopharmaceutical features. Tukey grouping, ANOVA and confidence interval (CI) were obtained for the comparison of the results. The ANOVA of the results indicated that the brands of (albendazole, ibuprofen, furosemide, glibenclamide, & carvedilol) were statistically different (p< 0.05). Hydrochlorothiazide brands were pharmaceutical equivalents (p > 0.05). A comparison of the results showed that 94.1% and 58.8% of the Brazilian and Nigerian brands passed respectively.
Keyword: Dissolution profile, Dissolution test, Low solubility drugs, Tablets
DOI: https://doi.org/10.31838/ijpr/2021.13.03.206
Download: Request For Article
 
Clients

Clients

Clients

Clients

Clients
ONLINE SUBMISSION
USER LOGIN
Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free